Xeris Biopharma Holdings Inc (XERS)
Cost of Revenue
$12.51M
Quarterly · Period ending: · USD
XERS Cost of Revenue
Latest reported$12.51Mperiod ending
Latest reported$12.51Mperiod ending
XERS Quarterly Cost of Revenue ($0.00 → $12.51M)
Quarterly cost of revenue
High-resolution chart · PNG
XERS cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 12,512,000 | |
| 13,284,000 | |
| 19,079,000 | |
| 10,996,000 | |
| 14,609,000 | |
| 8,728,000 | |
| 9,478,000 | |
| 13,593,000 | |
| 10,500,000 | |
| 5,971,000 | |
| 10,281,000 | |
| 8,201,000 | |
| 7,555,000 | |
| 5,319,000 | |
| 6,291,000 | |
| 5,260,000 | |
| 4,810,000 | |
| 6,273,000 | |
| 4,889,000 | |
| 3,220,000 | |
| 3,383,000 | |
| 1,826,000 | |
| 3,407,000 | |
| 2,832,000 | |
| 1,299,000 | |
| 1,790,000 | |
| 1,603,000 | |
| 10,000 | |
| 23,000 | |
| 0 | |
| 42,000 | |
| 0 | |
| 0 | |
| 42,000 | |
| 0 | |
| 0 | |
| 4,000 | |
| 0 |